Clinical Trial Update: Immunogenicity and Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With SLE: a Controlled Study [Phase 4]

View source ↗

Summary

This Phase 4 controlled study evaluated the immunogenicity and safety of a quadrivalent HPV vaccine in patients with systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: Tuen Mun Hospital | Conditions: Systemic Lupus Erythematosus | Phase 4 | Status: COMPLETED